⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 17, 2026BMJOpen Access

Meningitis B: All 15 year olds should be offered vaccine on NHS, say expert advisers

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to ensure all teenagers receive the MenB vaccine routinely at age 15 to prevent infections.
Expert recommendation for vaccination
Focus on teenagers
Routine immunization protocol
Supporting routine offering of MenB vaccine for 15-year-olds
Expected reduction in meningitis infections among teenagers
Enhancement of public health outcomes in the UK

Implication

Experts recommend routine MenB vaccination at age 15, suggesting improved healthcare outcomes for teenagers.

Abstract

All teenagers should be routinely offered a vaccine against meningitis B (MenB) at around 15 years of age, UK experts are recommending.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jacqui Wise (2026) studied this question.

synapsesocial.com/papers/6a5db9da8bd453d3397ab3b0 https://doi.org/10.1136/bmj-2026-100313

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Protecting UK adolescents and adults against meningococcal serogroup B diseasereview · 2018 · 7 citations
2Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020Original Research · 2020 · 322 citations
3United States Physicians' Knowledge, Attitudes, and Practices Regarding Meningococcal Vaccination for Healthy Adolescents and Young Adults2024 · 16 citations
4Exploring meningococcal serogroup B vaccination conversations under shared clinical decision-making in the US2024 · 3 citations
5P-570. Need for Broad Protection Against Invasive Meningococcal Disease Among US College StudentsReview · 2026

More related papers

Young Adult and Parent Willingness to Pay for Meningococcal Serogroup B Vaccination2024
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 20232024
Updated Recommendations for Use of Meningococcal Conjugate Vaccines—Advisory Committee on Immunization Practices (ACIP), 20102011

More from BMJ

How the brain changes during menopause—and why we still don’t know what it meansFri,
Postmarketing surveillance of medical devicesWed,